Eisai Co., Ltd. (ESAIY)
OTCMKTS
· Delayed Price · Currency is USD
9.25
-0.12 (-1.28%)
Oct 8, 2024, 4:00 PM EDT
Eisai Revenue
Eisai had revenue of 189.03B JPY in the quarter ending June 30, 2024, a decrease of -4.01%. This brings the company's revenue in the last twelve months to 733.85B, down -3.07% year-over-year. In the fiscal year ending March 31, 2024, Eisai had annual revenue of 741.75B, down -0.36%.
Revenue (ttm)
733.85B JPY
Revenue Growth
-3.07%
P/S Ratio
n/a
Revenue / Employee
66.31M JPY
Employees
11,067
Market Cap
10.38B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 741.75B | -2.65B | -0.36% |
Mar 31, 2023 | 744.40B | -11.82B | -1.56% |
Mar 31, 2022 | 756.23B | 110.28B | 17.07% |
Mar 31, 2021 | 645.94B | -49.68B | -7.14% |
Mar 31, 2020 | 695.62B | 52.79B | 8.21% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Medexus Pharmaceuticals Inc. | 108.78M |